Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950172-04-002327
Filing Date
2004-10-06
Accepted
2004-10-06 15:44:29
Documents
1
Effectiveness Date
2004-10-06

Document Format Files

Seq Description Document Type Size
1 ch420065.txt DEFA14A 8339
  Complete submission text file 0000950172-04-002327.txt   9888
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: DEFA14A | Act: 34 | File No.: 001-12493 | Film No.: 041068323
SIC: 2836 Biological Products, (No Diagnostic Substances)